Hepatology Research

SCI SCIE

国际简称：HEPATOL RES 参考译名：肝病学研究

主要研究方向：医学-胃肠肝病学非预警期刊审稿周期：约1.2月

《肝病学研究》(Hepatology Research)是一本由Wiley-Blackwell Publishing Ltd出版的以医学-胃肠肝病学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
151 年发文量
3.7 IF影响因子
未开放 是否OA
66 H-index
1997 创刊年份
Monthly 出版周期
English 出版语言

Hepatology Research (formerly International Hepatology Communications) is the official journal of the Japan Society of Hepatology, and publishes original articles, reviews and short comunications dealing with hepatology. Reviews or mini-reviews are especially welcomed from those areas within hepatology undergoing rapid changes. Short communications should contain concise definitive information.

[ 查看全部 ]

投稿咨询加急咨询

Hepatology Research期刊信息

ISSN：1386-6346
出版语言：English
是否OA：未开放
E-ISSN：1872-034X
出版地区：ENGLAND
是否预警：否
出版商：Wiley-Blackwell Publishing Ltd
出版周期：Monthly
创刊时间：1997
开源占比：0.1139
Gold OA文章占比：28.57%
OA被引用占比：0.0953...
出版国人文章占比：0.12
出版撤稿占比：0
研究类文章占比：95.36%

Hepatology Research CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

6.5

1.117

1.24

学科类别	分区	排名	百分位
大类：Medicine 小类：Infectious Diseases	Q1	71 / 361	80%
大类：Medicine 小类：Hepatology	Q2	24 / 88	73%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Hepatology Research中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	3区

Hepatology Research JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	49 / 153	68.3
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	43 / 153	72.22

Hepatology Research历年数据统计

影响因子

中科院分区

Hepatology Research中国学者发文选摘

1、The Microbiome-Gut-Liver Axis Drives Post-Kasai Fibrosis in Biliary Atresia: From Mechanism to Precision Interventio
Author: Cheng, Jiwen

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70184
2、Lenvatinib Promotes Metabolic Reprogramming Through RTK to Inhibit Hepatocellular Carcinoma Proliferation and Metastasi
Author: Zhao, Xiaofang; Yan, Shengxiang; Meng, Jing; Wang, Limin

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70164
3、Comment on Using Serum Creatinine-to-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosi
Author: Wang, Weiming; Wang, Miaofeng; Tang, Lifeng

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70183
4、Letter to the Editor: Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysi
Author: Jiang, Chengli

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70144
5、Comment on Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japa
Author: Jin, Haonan

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70145
6、Letter to the Editor: Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japa
Author: Ke, Haigu; Shi, Wenwen; Sheng, Minhui

Journal: HEPATOLOGY RESEARCH. 2026; Vol. , Issue , pp. -. DOI: 10.1111/hepr.70154
7、Associations of serum carotenoids with cardiovascular disease mortality among patients with metabolic dysfunction-associated steatotic liver diseas
Author: Wang, Qian-Qian; Zhu, Jing; Miao, Lin-Jun; Lv, Si-Ang; Shen, Guo-Yin; Wu, Jun

Journal: HEPATOLOGY RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.1111/hepr.14215
8、CXCL6 Is a Novel Biliary Marker and a Downstream Target of MMP7 in Biliary Atresi
Author: Kong, Fanyang; Jiang, Jingying; Du, Min; Dong, Rui; Chen, Gong; Zheng, Shan; Wang, Junfeng

Journal: HEPATOLOGY RESEARCH. 2025; Vol. , Issue , pp. -. DOI: 10.1111/hepr.14217